GlassScriptPhysician profile
Stephanie Coates
NPI 1710047451
$4,694.27
in general payments reported to CMS, 2019-2025
20 companies · $619 in 2025
The $619 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $938 · 2020: $377 · 2021: $468 · 2022: $654 · 2023: $719 · 2024: $919 · 2025: $619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,127 · Entertainment: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,127.27 |
| Entertainment | $130.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,090.57 | 2022-2025 | Miebo, Xiidra, Infuse |
| Johnson & Johnson Vision Care, INC. | $785.64 | 2020-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $696.32 | 2019-2021 | |
| Optos, INC. | $301.37 | 2020-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Abbvie INC. | $243.06 | 2023-2024 | Vuity |
| Genentech USA, INC. | $217.80 | 2023 | |
| Sun Pharmaceutical Industries INC. | $186.74 | 2019-2020 | |
| Sight Sciences, INC. | $132.65 | 2021-2022 | |
| Ocular Therapeutix, INC. | $127.40 | 2024 | Dextenza |
| Abb Con-Cise Optical Group LLC | $126.31 | 2019-2024 | Contact Lens, Spectacle Lenses |
| Allergan, INC. | $124.53 | 2022 | |
| Horizon Therapeutics Plc | $121.33 | 2022 | |
| Astellas Pharma US INC | $105.76 | 2024 | Izervay |
| Coopervision INC. | $92.16 | 2024 | Onefit Contact Lens |
| Alcon Research LLC | $86.86 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visionix USA, INC | $70.55 | 2022 | |
| Alcon Vision LLC | $62.88 | 2024 | Clareon |
| Visioneering Technologies, INC. | $56.75 | 2019 | |
| Optovue, INC. | $48.39 | 2019 | |
| Carl Zeiss Meditec Ag | $17.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Coates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.